Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Business

UK signs 10-year deal with Moderna to produce 250m vaccines in event of another pandemic

by December 23, 2022
December 23, 2022
UK signs 10-year deal with Moderna to produce 250m vaccines in event of another pandemic

The UK government has signed a 10-year deal with Moderna to produce upwards of 250m vaccines a year in the event of a pandemic.

The investment will give NHS patients access to UK-made mRNA vaccines while a new innovation and technology centre will be created, with 150 highly skilled jobs.

In a major boost for the UK as a life sciences superpower, it will also boost health research and lead to the UK Health Security Agency (UKHSA) working with Moderna in vaccine development.

The partnership, led by the Vaccine Taskforce , was announced in June of this year.

By producing vaccines in the UK, it will allow production to be massively scaled up in the event of a major health emergency, such as another pandemic or new covid variant.

Secretary of State for Health and Social Care, Steve Barclay, said: “This time 2 years ago, the UK was the first country in the world to administer a COVID vaccine outside of a clinical trial. Since then, countless lives have been saved across the world and more than 150 million doses have been given in the UK alone.”

“It is vital we invest in fighting future variants of this disease as well as other deadly viruses that are circulating, such as seasonal flu and RSV, and this partnership with Moderna will also strengthen our ability to respond to any future pandemics.

“By boosting our onshore vaccine manufacturing capability, we are a step closer to becoming the leading global hub for life sciences. This partnership will support our crucial mission to protect the people of the UK and across the world through the development of revolutionary vaccines and research.”

The deal was heralded by Dr Jenny Harries, Chief Executive of UKHSA, who said it “will now be taking this forward as a vital part of our preparedness against future respiratory virus threats, including COVID-19.”

“Our scientists have been monitoring the evolution of the virus throughout the pandemic, and assuring continued protection for the population. This partnership will take the winning ways of working with industry and build the nation’s resilience, giving us rapid access to vaccines. We look forward to working closely with Moderna and playing a key role in supporting the government’s ambitious life sciences strategy.”

Stéphane Bancel, Chief Executive Officer of Moderna, said: “Our new state-of-the-art facility will bring mRNA manufacturing to UK shores, providing the UK public with access to pandemic response capabilities through Moderna COVID-19 vaccines and future respiratory virus vaccine candidates.”

Richard Torbett, Chief Executive, Association of the British Pharmaceutical Industry (ABPI) said: “This partnership is fantastic news for British manufacturing and UK-based science and research. It is an important reminder that the Life Sciences Industry has the potential to be a key growth driver for the UK economy.”

Read more:
UK signs 10-year deal with Moderna to produce 250m vaccines in event of another pandemic

0
FacebookTwitterGoogle +Pinterest
previous post
Festive season fuels 2.5 million visits to the capital post-Covid
next post
Flexible office occupancy rates recover to pre-pandemic levels

You may also like

Waracle secures three-year digital transformation partnership with SP...

August 26, 2024

Fuel tax cut in UK among lowest in...

August 1, 2022

Waitrose shoppers survey shows fish heads and spam...

October 20, 2022

The Business of Beats: Strategies for Aspiring Music...

January 18, 2024

Labour finalising £500m rescue for Tata Steel’s Port...

September 10, 2024

‘Fuel duty freeze is a reckless waste of...

February 8, 2023

The team behind the experience

April 9, 2024

Staff at nine train companies to stage 24-hour...

August 31, 2022

BMW braced for €1bn hit as Trump’s tariffs...

March 14, 2025

Guest posting will boost your business visibility online...

January 11, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Trump warns of ‘serious consequences’ if Elon Musk funds Democrats

      June 7, 2025
    • Musk jokes about reconsidering stance on Big Beautiful Bill after Schiff’s praise

      June 7, 2025
    • Musk deletes explosive posts about Trump and Epstein files

      June 7, 2025
    • House witness flips script on Dem who ambushed him during hearing with unearthed tweet: ‘Iceberg is ahead’

      June 7, 2025
    • Call with China’s Xi, and Trump-Musk exchange fueled barbs during 20th week in office

      June 7, 2025
    • Trump’s conservative allies warn Congress faces critical ‘test’ with $9.4B spending cut proposal

      June 7, 2025

    Categories

    • Business (8,152)
    • Investing (2,019)
    • Politics (15,568)
    • Stocks (3,136)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved